Print | Need Larger Text?

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2009-0606

2. Registrant Information.

Registrant Name (Full Legal Name no abbreviations): Arysta LifeScience North America, LLC

Address: 15401 Weston Parkway, Suite 150

City: Cary

Prov / State: NC

Country: USA

Postal Code: 27513

3. Select the appropriate subform(s) for the incident.

Scientific Study

4. Date registrant was first informed of the incident.

5. Location of incident.

6. Date incident was first observed.

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

PMRA Registration No.       PMRA Submission No.       EPA Registration No.

Product Name:

• Active Ingredient(s)
  • ACEQUINOCYL

7. b) Type of formulation.

Application Information

8. Product was applied?

Unknown

9. Application Rate.

10. Site pesticide was applied to (select all that apply).

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform VII: Scientific Study

1. Study Reference

Title Acequinocyl: New Freshwater Invertebrate Toxicity Data

Date 14-NOV-08

2. a) Is an extension needed to translate the document?

No

3. Type of incident identified in the study

New health or environmental hazard

4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)

In a meeting on October 9, 2008, Arysta LifeScience learned that EU regulators required a study in which the toxicity of acequinocyl was evaluated in eight different freshwater invertebrate species. Arysta Life Sciences has requested the study but as of yet has not received it. Please refer to the letter submitted.

5. a) Was the study discontinued before completion?

No

5. b) Provide the reason for discontinuation

6. If the study is ongoing, what is the expected completion date?

For Registrant use only

7. Provide supplemental information here

Study to be submitted when available